Therefore, two types of future investigations are necessary; a follow-up study of post-stroke patients for recurrent infarction and a cohort study of healthy elderly subjects afflicted by ischemic stroke, both of which should focus on CD14highCD16+ intermediate and CD14 dimCD16high non-classical monocytes. This evidence concerns the gene CD14 and stroke disorder.